Clinical Trials Browser

OTHER × Lung Neoplasms × Aspirin × Clear all

NCT03654105 2024-03-07

SMILE

Phase 2 Active not recruiting

Inflammation, Lung Neoplasms, Motor Activity, Smoking Cessation

NCT03532698 2020-07-23

Combination of Osimertinib and Aspirin to Treat Osimertinib Resistance Non-small Cell Lung Cancer ( NSCLC)

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms